Maze Therapeutics (MAZE) Shares Issued (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Shares Issued data on file, last reported at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 15.11% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 15.11% YoY), and the FY2025 full-year result was $4.8 million, up 476.32% from the prior year.
• Shares Issued climbed to $6.1 million in Q1 2026, from $4.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $6.1 million in Q1 2026 to a low of $831177.0 in Q4 2024.
• A 3-year average of $4.7 million and a median of $5.3 million in 2025 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued surged 476.32% in 2025 and advanced 15.11% in 2026, its largest moves.
• Tracing MAZE's Shares Issued over 3 years: stood at $831177.0 in 2024, then surged by 476.32% to $4.8 million in 2025, then climbed by 26.82% to $6.1 million in 2026.
• Business Quant data shows MAZE's Shares Issued at $6.1 million in Q1 2026, $4.8 million in Q4 2025, and $5.7 million in Q3 2025.